The use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization.

Saved in:
Bibliographic Details
Title: The use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization.
Authors: Athanasiou E; Department of Medicine, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece., Papageorgiou S; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Department of Molecular and Cell Biology, University of Leicester, Leicester, United Kingdom., Dafni MF; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece., Kelesis I; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; School of Medicine, Poznań University of Medical Sciences, Poznań, Poland., Vasileiou M; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece., Tatsiou T; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Department of Biology, University of Crete, Heraklion, Crete, Greece., Kouveloglou V; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece., Kanatas P; Department of Medicine, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece., Stouras I; Department of Medicine, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece., Gatsis A; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece., Agiassoti VT; Department of Medicine, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece., Nasimpian P; Department of Medicine, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece., Dafnoudis D; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Applied Bioinformatics Master Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Degaita K; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece., Verras GI; Cancer Prevention Research Group in Greece, Kifisias Avenue 44, Marousi, Greece.; Department of Surgery, General University Hospital of Patras, Patra, Greece., Alexiou A; Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, NSW 2770, Australia.; AFNP Med, Wien, 1030, Austria., Papadakis M; Department of Surgery II, University Hospital Witten-Herdecke, University of Witten-Herdecke, Wuppertal, 42283, Germany., Kamal MA; Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.; King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.; Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.; Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770, Australia.; Novel Global Community Educational Foundation, Hebersham, NSW 2770, Australia.
Source: Current medicinal chemistry [Curr Med Chem] 2025; Vol. 32 (2), pp. 214-237.
Publication Type: Journal Article; Review
Journal Info: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 9440157 Publication Model: Print Cited Medium: Internet ISSN: 1875-533X (Electronic) Linking ISSN: 09298673 NLM ISO Abbreviation: Curr Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-533X
DOI:10.2174/0109298673278897231229121524